Open Label Extension study for PPSO-003 (PPSO-004)
Research payments
$335,753
Through program year 2020, $335,753 in research payments was reported against Open Label Extension study for PPSO-003 (PPSO-004), across 35 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $335,753 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Vivian Laquer Irvine, CA Named on 8 payments
- David Cohen Macon, GA Named on 8 payments
- Pearl Kwong Jacksonville, FL Named on 6 payments
- Navid Ezra Thousand Oaks, CA Named on 5 payments
- Scott Fretzin Indianapolis, IN Named on 3 payments
- Emily Becker San Antonio, TX Named on 2 payments
- Lisa Arkin Philadelphia, PA Named on 2 payments
- Giovanna Ciocca Miami, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.